Is HPV vaccination in pregnancy safe?

Quadrivalent HPV Vaccination and Risk of Multiple Sclerosis and Other Demyelinating Diseases of the Central Nervous System

(2015) Nikolai Madrid Scheller et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials

(2015) Aimée R Kreimer et al.   LANCET ONCOLOGY

A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

(2015) Elmar A. Joura et al.   NEW ENGLAND JOURNAL OF MEDICINE

An Overview of Quadrivalent Human Papillomavirus Vaccine Safety

(2015) Michelle Vichnin et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Reduced dose human papillomavirus vaccination: An update of the current state-of-the-art

(2015) Zheng Quan Toh et al.   VACCINE

Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial

(2015) Orestis A Panagiotou et al.   BMJ-British Medical Journal

Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial

(2015) Orestis A Panagiotou et al.   BMJ-British Medical Journal

Assessing HPV vaccine coverage in Australia by geography and socioeconomic status: are we protecting those most at risk?

(2014) Bianca Barbaro et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Quadrivalent Human Papillomavirus Vaccine and the Risk of Venous Thromboembolism

(2014) Nikolai Madrid Scheller et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Pooled analysis of large and long-term safety data from the human papillomavirus-16/18-AS04-adjuvanted vaccine clinical trial programme

(2014) Maria-Genalin Angelo et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study

(2013) L. Arnheim-Dahlstrom et al.   BMJ-British Medical Journal

Uptake of the human papillomavirus-vaccination within the free-of-charge childhood vaccination programme in Denmark

(2011) Katarina Widgren et al.   VACCINE

Safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for cervical cancer prevention: A pooled analysis of 11 clinical trials

(2010) Dominique Descamps et al.   Human vaccines & immunotherapeutics

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

(2010) Silvia de Sanjose et al.   LANCET ONCOLOGY

Pregnancy Outcomes From the Pregnancy Registry of a Human Papillomavirus Type6/11/16/18 Vaccine

(2009) Adrian Dana et al.   OBSTETRICS AND GYNECOLOGY

Pregnancy and Infant Outcomes in the Clinical Trials of a Human Papillomavirus Type 6/11/16/18 Vaccine

(2009) Suzanne M. Garland et al.   OBSTETRICS AND GYNECOLOGY